title: Can olanzapine cause delirium in the elderly?
abstract: OBJECTIVE
  To report a case of delirium probably caused by the atypical antipsychotic olanzapine in a 74-year-old man with dementia.
  
  
  METHODS
  A 74-year-old white man with a diagnosis of severe dementia of mixed etiology with behavioral disturbances was admitted to an urban teaching hospital for increasing agitation in the context of worsening dementia. Olanzapine 2.5 mg each evening was started for agitation, and the dose was titrated to 5 mg each evening with additional emergent doses. Memantine, an N-methyl-D-aspartate antagonist, was increased from the admission dose of 10 mg/day to 15 mg/day. The patient developed symptoms of delirium on hospital day 4. Neuroleptic malignant syndrome and other causes of delirium were ruled out. Discontinuation of olanzapine resulted in resolution of the delirium.
  
  
  CONCLUSIONS
  Antipsychotic medications are commonly used to treat symptoms of delirium. Atypical antipsychotics are better tolerated in the elderly because of their fewer adverse reactions compared with other antipsychotics. Olanzapine has been successfully used in the treatment of delirium. However, there have been case reports of delirium associated with olanzapine, probably related to its intrinsic anticholinergic effect. Application of the Naranjo probability scale indicated a probable relationship between the onset of delirium and the use of olanzapine in this patient. As of December 1, 2005, this was the second such report of a case in the elderly.
  
  
  CONCLUSIONS
  Although olanzapine is useful in the treatment of delirium, elderly patients treated with this drug can develop delirium and hence should be closely monitored.
authors.affiliation: Department of Psychiatry, School of Medicine, Yale University, New Haven, CT 06519-3202, USA.
authors.forename: Christine J
authors.initials: CJ
authors.lastname: Lim
authors.forename: Christina
authors.initials: C
authors.lastname: Trevino
authors.forename: Rajesh R
authors.initials: RR
authors.lastname: Tampi
mesh_terms: D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D003693:Delirium / Q000139:chemically induced* / Q000175:diagnosis; D003704:Dementia / Q000188:drug therapy; D006801:Humans; D008297:Male; D000077152:Olanzapine
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine